Henrik Lindman

Department of Immunology, Genetics and Pathology, Experimental and Clinical Oncology; Clinical Oncology, Faculty of Medicine, Uppsala University Hospital, Uppsala, 751 85, Sweden, Sweden

I do not have any relevant financial / non-financial relationships with any proprietary interests.

Presentation(s):

• End-of-life Endocrine Treatment of Older Hormone Receptor-positive Metastatic Breast Cancer Patients: A Nationwide Swedish Retrospective Cohort Study

  Sunday, August 28, 2022
  2:00 PM – 2:15 PM CEST